Two-Year Data From Phase 2 Trial Of Genzyme Gaucher Disease Oral Compound Suggest Continued Improvement Across All … (Medical News Today)

February 12th, 2010 by IvorySauer82


Genzyme Corporation (NASDAQ: GENZ) announced two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline

Tags: , , , , , , , , , ,

Published by IvorySauer82 on Feb 12, 2010 under Object | Post your comment now

Additional data from Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease presented (News-Medical-Net)

February 11th, 2010 by IvorySauer82


Protalix BioTherapeutics, Inc., announced today that additional data from the Company’s pivotal Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease was presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010 in Miami, Florida, during an oral session titled, “Novel Enzyme Replacement Therapy for Gaucher Disease: Phase III Pivotal Clinical …

Tags: , , , , , , , , ,

Published by IvorySauer82 on Feb 11, 2010 under Object | Post your comment now

Biochemistry department develops new understanding of Fabry disease (The Massachusetts Daily Collegian)

February 11th, 2010 by Andrianq


Researchers in the department of biochemistry led by Dr.

Tags: , , , , , , , , , , ,

Published by Andrianq on Feb 11, 2010 under Object | Post your comment now

Using Nitroglycerin To Treat Prostate Cancer Shows Potential To Halt Disease (Medical News Today)

February 10th, 2010 by admin


Treatment of prostate cancer using a very low dose of nitroglycerin may slow and even halt the progression of the disease without the severe side effects of current treatments, Queen’s University researchers have discovered The findings are the result of the first-ever clinical trial using nitroglycerin to treat prostate cancer. The 24-month, Phase II study targeted 29 men with increasing levels …

Tags: , , , , , , , , , , , ,

Published by admin on Feb 10, 2010 under Object | Post your comment now

Calculate Your Heart Disease Risk (WJXT Jacksonville)

February 9th, 2010 by MikeWink


Are you at risk for heart disease? Use this calculator to find out.

Tags: , , , , , , , , , , , , ,

Published by MikeWink on Feb 9, 2010 under Object | Post your comment now